Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

2nd European
CAR T-Cell Meeting

Sitges, 30 January–1 February, 2020

VJHemOnc are pleased to be official media partners with the EBMT and EHA for the 2nd European CAR T-cell Meeting, which took place on 30th Jan – 1st Feb in Sitges, Spain.

Key topics at this year’s meeting included perspectives on CAR T-cell manufacturing, strategies to improve efficacy and safety profiles, nursing and patient advocacy.

Explore the latest updates in the exciting field of CAR T-cell therapy by viewing our interviews with key experts!

Trial Updates

View all
1:52
ZUMA-1 safety management study: early use of steroids helps manage side effects
Marie José Kersten • 30 Jan 2020
1:55
CRISPR/Cas9 edited T-cells in MM and sarcoma
Bruce Levine • 30 Jan 2020

Manufacturing

View all
3:59
UCL CAR T-cell program: advancing CAR T-cell manufacturing
Claire Roddie • 30 Jan 2020
2:09
Accessible and affordable CAR T-cell production in academia: the Barcelona group’s experience
Manel Juan Otero • 30 Jan 2020

Nursing

View all
4:24
CAR-T Meeting 2020: nurses’ sessions highlights
John Murray • 30 Jan 2020
2:49
The role of nurses in CAR T-cell therapy
Erik Aerts • 30 Jan 2020

Patient Advocacy

View all
2:20
CAR T-cell therapy access and reimbursement: the patient’s perspective
Bregje Verhoeven • 30 Jan 2020
3:04
Patient perspectives of CAR T-cell regulation
Natacha Bolaños • 30 Jan 2020
The content of VJHemOnc is intended for healthcare professionals